Article

From C-Section to Childhood Asthma: New Evidence Sheds Light on the Relationship

Author(s):

The relationship between C-section and childhood asthma has been investigated before, however, previous results have yielded conflicting evidence.

From C-Section to Childhood Asthma: New Evidence Sheds Light on the Relationship

An association was identified between emergency cesarean section (C-section) and childhood asthma, according to recent data. This relationship has been investigated before, however, previous results have yielded conflicting evidence.

While some studies showed the absence of a connection, others have indicated the disruption of infant intestinal flora that occurs during C-section can facilitate the development of allergens.

The aim of this study was to explore how the mode of delivery related to asthma development at 7, 11, or 14 years. Additionally, investigators examined persistent asthma and adolescent onset asthma by analyzing data acquired from the UK Millennium Cohort Study.

Does the Mode of Delivery Determine Asthma Risk?

In a research letter regarding the UK Millennium Cohort Study, Amy O’Connor, School of Public Health, University College Cork, Cork, Ireland, and a team of investigators hypothesized that if the disruption of infant intestinal microflora was responsible for the link between C-section and asthma, an association would be observed between planned C-section and asthma in this study.

The mode of delivery was categorized as one of the following: ‘spontaneous vaginal delivery’, ‘assisted vaginal delivery’, ‘induced vaginal delivery’, ‘emergency C-section’, ‘planned C-section’ and ‘C-section after induction of labor’. Investigators defined the variable as the effect of any intervention during labor, as opposed to no intervention.

One of the principal findings was the link between emergency C-section and asthma at ages 7, 11, and 14 years. According to results, few associations were observed between assisted and induced vaginal delivery and asthma at the age of 11 and induced vaginal delivery and wheezing at 7 years.

The other principal finding came from assessing the relationship between planned C-section and asthma–after crude and adjusted model analyses, investigators observed no associations.

In the research letter, it was speculated that the positive associations could potentially include a disruption in the infant intestinal microflora following C-section. However, investigators emphasized that in that case, the expectation was related to planned C-section.

Considerations & Conclusions

Some limitations noted by investigators included the possible role of recall bias for self-reported potential confounders, and that the data was collected before asthma status of the child was known. In instances of any misclassification, the letter stated this could bias results toward the null due to the likelihood of it being non-differential.

By confounding by indication, investigators didn’t have any information regarding the reasoning for planned or emergency C-section scenarios, which they explained could have influenced results.

The large, population-based cohort nationally represented children born in the UK between 2000-2002, which strengthened this research. Additionally, the outcome measure was determined by a validated questionnaire that exhibited a specificity of 93%, and is widely used to measure childhood asthma.

Unlike previous investigations, this one categorically distinguished planned C-section, and emergency C-section. Complications of pregnancy, maternal asthma, and several maternal and socio-economic factors were considered when controlling for potential confounders.

“In conclusion, children born by emergency CS, but not planned CS had an increased likelihood of asthma diagnosis,” investigators wrote. “These results suggest that the association may be due to confounding by indication or other residual confounding factors, and unlikely to be causal based on the microbiome theory.”

The study "Mode of delivery and asthma in childhood and adolescence: Findings from the Millennium Cohort Study" was published in Clinical & Experimental Allergy.

Related Videos
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
© 2024 MJH Life Sciences

All rights reserved.